Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 277, doi. 10.1177/1060028020957048
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2021 AND VI 55 AND IP 3
Results: 16
1
2
Caring for the COVID Patient: A Clinical Pharmacist's Perspective.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 413, doi. 10.1177/1060028020954224
- By:
- Publication type:
- Article
3
Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 303, doi. 10.1177/1060028020953501
- By:
- Publication type:
- Article
4
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 286, doi. 10.1177/1060028020952749
- By:
- Publication type:
- Article
5
Phenobarbital Monotherapy for the Management of Alcohol Withdrawal Syndrome in Surgical-Trauma Patients.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 294, doi. 10.1177/1060028020949137
- By:
- Publication type:
- Article
6
Continuing Burden of Refractory Epilepsy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
7
Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 311, doi. 10.1177/1060028020947173
- By:
- Publication type:
- Article
8
Suspected Drug-Induced Rhabdomyolysis From the Combination of Atorvastatin, Amiodarone, and Ciprofloxacin.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
9
Toward Multistate Pharmacy Practice: Enhancing Mobility and Portability of Pharmacist Licensure.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 409, doi. 10.1177/1060028020945254
- By:
- Publication type:
- Article
10
Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 318, doi. 10.1177/1060028020941113
- By:
- Publication type:
- Article
11
A Clinical Review of Biosimilars Approved in Oncology.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 362, doi. 10.1177/1060028020944596
- By:
- Publication type:
- Article
12
Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 390, doi. 10.1177/1060028020944233
- By:
- Publication type:
- Article
13
A Systematic Review on the Use of Sacubitril/Valsartan Initiated Prior to Discharge in Hospitalized Patients With Heart Failure.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 378, doi. 10.1177/1060028020943940
- By:
- Publication type:
- Article
14
PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 354, doi. 10.1177/1060028020943527
- By:
- Publication type:
- Article
15
New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 330, doi. 10.1177/1060028020941852
- By:
- Publication type:
- Article
16
Peanut Allergen Powder-dnfp: A Novel Oral Immunotherapy to Mitigate Peanut Allergy.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 344, doi. 10.1177/1060028020944370
- By:
- Publication type:
- Article